Several of us bought into this stock Friday May 8th in the 1.33 - 1.43 area. Volume has exploded and its currently trading above its former 52 week high.

The reason for all the hype is that their drug Ampligen for chronic fatigue syndrome is due for a FDA decision on May 25th. That is Memorial day so look for the 26th.

Hype alone should drive this higher until the decision.

Here is an article that tells more about why it has our interest.





Drug Approvals - A Date With Destiny...
5/11/2009 3:14 AM ET

(RTTNews) - The biotechnology sector is a risky investment arena and investing in such companies requires a great deal of patience. Drug companies take years -- even decades and burn a tremendous amount of cash to bring a drug to the market.

Some drugs pass the FDA muster easily, while some struggle through the arcane process of regulatory approval. For a one-trick pony company, which does not have a safety net for failure of the lead compound, the FDA decision can seal the fate of the company.

However, despite the regulatory setbacks, some companies exude a steely determination to bring their drugs to market and their patience has been amply rewarded. Some of the recent classic examples are Dendreon Corp. (DNDN) and Vanda Pharmaceuticals Inc. (VNDA).

Two years after Dendreon's prostate cancer vaccine Provenge was rejected by the FDA, the drug has got a second chance now. Dendreon plans to refile for FDA approval in the fourth-quarter of this year. The stock, which hit a 52-week low of $2.55 on March 9, 2009, now trades around $19.

Vanda is yet other example of patience and an iron resolve. After initially being rebuffed by the FDA last year, Vanda's schizophrenia drug Fanapt (Iloperidone) made it across the finish line by winning the regulatory approval on May 6, 2009. The stock, which hit an all-time low of $0.45 on December 23, 2008, now trades around $9.

The following are the companies, which are expected to hear the FDA's decision on their drugs during this month.

Hemispherx Biopharma Inc. (HEB: News ), which is awaiting FDA approval of its experimental drug Ampligen for chronic fatigue syndrome, set a new 52-week high of $1.50 on Friday. The FDA decision is due on May 25.

Over the past one-week alone, Hemispherx gained a whopping 160%. The current run up in stock price of Hemispherx can be attributed to the prospects of flu profits. The risk of a swine flu pandemic has boosted the share prices of anti-viral drug companies and Hemispherx is one among them.

Ampligen, which has earned the sobriquet, "a drug in search of a disease", is also in preclinical testing for avian flu in the U.S., Japan and Canada. On April 27, it was announced that the Japanese government is accelerating the Ampligen research program in human volunteers. The recent emergence of a new swine flu strain with high associated mortality in Mexico provides additional significance to the Japanese studies.

Hemispherx's collaborative partner in Japan, Biken Corporation has also successfully completed a series of animal/preclinical tests on Ampligen as an enhancer for seasonal influenza vaccine.

Good luck....my only advice....take profits when they're showing.

__________________
Disclaimer: Any stocks I comment on are my opinion only. Play the stock market at your own risk!
My Bottom Plays:BP RIG
SMC - THE BEST STOCK MARKET FORUM
FREE LIVE CHAT if you join Stock Market Cats
"A government big enough to give you everything you need, is big enough to take everything you have." - Thomas Jefferson

Sold HEB a few days ago but rebought 5-15-09 @ 1.22.

Closed yesterday 5-18-09 @ 1.93. Looks like its going to be another nice mover today. Premarket @ 2.15.

Anyone else still in?

I bought back in at 1.55 yesterday, but sold at the end of the day at 1.92. Im thinking about re entering at the open. Hoping it pulls back some.

__________________


"Money was never a big motivation for me, except as a way to keep score. The real excitement is playing the game."

-Donald Trump

“We all have great inner power. The power is self-faith. There's really an attitude to winning. You have to see yourself winning before you win. And you have to be hungry. You have to want to conquer.”

-Arnold Schwarzenegger

HEB announces another offering and price drops from 2.20 - 1.40

I sold @ 1.45 and I'm done with these crooks. Hopefully they will have 10 more offerings and drive the price to .02

BTW... I hope their drug gets a big NO from the FDA

Here's a 30-month chart on HEB. As you can see HEB closed at a 29-month high:


30-day chart (Notable features: highest volume in their history since being listed in 1997, 3rd time with +20 million volume, 1st time with +23 million volume, actual volume 27.5 million, pSAR flipped bullish, most indicators remain bullish, and HEB is now trading above every moving average:


Not trying to get too excited here cause I learned a lesson on XOMA.... On a good note HEB already diluted their shares on two occasions recently so if there is another crash, it won't be due to dilution...GLTA!

__________________
My Latest Creation: A Stock Alert Website

***Link posted with the SMC co-founder
stamp of approval from CaribbeanCat***

My Dow 30 Stock Charts List

__________________
My Latest Creation: A Stock Alert Website

***Link posted with the SMC co-founder
stamp of approval from CaribbeanCat***

My Dow 30 Stock Charts List

Removing as I believe the article I posted was incorrect

HEB Chart-

__________________
"People are not remembered by how few times they fail, but how often they succeed."
- Thomas Edison

http://motorbicycling.com/
motorbicycles that get over 150 MPG. Stop by and learn how to beat the gas wars.....

The Green Revelotion has begun. Save the planet. Stop by our green energy site at:
http://www.nature2energy.com


Articles by Gwitt
http://www.triond.com/users/GWitt